Purendan alleviates non-alcoholic fatty liver disease in aged type 2 diabetic rats via regulating mTOR/S6K1/SREBP-1c signaling pathway.
Biomed Pharmacother
; 148: 112697, 2022 Apr.
Article
in En
| MEDLINE
| ID: mdl-35176709
Full text:
1
Database:
MEDLINE
Traditional Medicines:
Medicinas_tradicionales_de_asia
/
Medicina_china
Main subject:
Diabetes Mellitus, Experimental
/
Diabetes Mellitus, Type 2
/
Non-alcoholic Fatty Liver Disease
Type of study:
Prognostic_studies
Language:
En
Journal:
Biomed Pharmacother
Year:
2022
Type:
Article